Two genes in the transforming growth factor-beta (TGF-β) signaling pathway, ENG and ACVRL1, were discovered almost two decades ago, and mutations in these genes have been reported to cause up to 85% of HHT cases. Here, ACVRL1 is linked to hereditary hemorrhagic telangiectasia.